{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:33:21Z","timestamp":1791311601115,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11060-015-1978-8","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T07:52:04Z","timestamp":1446191524000},"page":"361-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma"],"prefix":"10.1007","volume":"126","author":[{"given":"Julia","family":"Tichy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Spechtmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Hattingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Senft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Foerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"1978_CR1","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1158\/0008-5472.CAN-04-1337","volume":"64","author":"H Ohgaki","year":"2004","unstructured":"Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892\u20136899","journal-title":"Cancer Res"},{"key":"1978_CR2","first-page":"1229","volume":"35","author":"N Okonogi","year":"2015","unstructured":"Okonogi N, Shirai K, Oike T, Murata K, Noda SE, Suzuki Y, Nakano T (2015) Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme. Anticancer Res 35:1229\u20131235","journal-title":"Anticancer Res"},{"key":"1978_CR3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"1978_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","volume":"8","author":"LF Eng","year":"1985","unstructured":"Eng LF (1985) Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203\u2013214","journal-title":"J Neuroimmunol"},{"key":"1978_CR5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","volume":"25","author":"LF Eng","year":"2000","unstructured":"Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439\u20131451","journal-title":"Neurochem Res"},{"key":"1978_CR6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0404.2007.00889.x","volume":"116","author":"T Brommeland","year":"2007","unstructured":"Brommeland T, Rosengren L, Fridlund S, Hennig R, Isaksen V (2007) Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurol Scand 116:380\u2013384","journal-title":"Acta Neurol Scand"},{"key":"1978_CR7","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1002\/cncr.28949","volume":"120","author":"J Gallego Perez-Larraya","year":"2014","unstructured":"Gallego Perez-Larraya J, Paris S, Idbaih A, Dehais C, Laigle-Donadey F, Navarro S, Capelle L, Mokhtari K, Marie Y, Sanson M, Hoang-Xuan K, Delattre JY, Mallet A (2014) Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma. Cancer 120:3972\u20133980","journal-title":"Cancer"},{"key":"1978_CR8","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awm263","volume":"130","author":"CS Jung","year":"2007","unstructured":"Jung CS, Foerch C, Schanzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M (2007) Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 130:3336\u20133341","journal-title":"Brain"},{"key":"1978_CR9","first-page":"1327","volume":"26","author":"CS Jung","year":"2011","unstructured":"Jung CS, Unterberg AW, Hartmann C (2011) Diagnostic markers for glioblastoma. Histol Histopathol 26:1327\u20131341","journal-title":"Histol Histopathol"},{"key":"1978_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT (2014) Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 31:19\u201325","journal-title":"J Neurotrauma"},{"key":"1978_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1373\/clinchem.2011.172676","volume":"58","author":"C Foerch","year":"2012","unstructured":"Foerch C, Niessner M, Back T, Bauerle M, De Marchis GM, Ferbert A, Grehl H, Hamann GF, Jacobs A, Kastrup A, Klimpe S, Palm F, Thomalla G, Worthmann H, Sitzer M (2012) Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem 58:237\u2013245","journal-title":"Clin Chem"},{"key":"1978_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3171\/2013.3.JNS122226","volume":"119","author":"EK Nduom","year":"2013","unstructured":"Nduom EK, Yang C, Merrill MJ, Zhuang Z, Lonser RR (2013) Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J Neurosurg 119:427\u2013433","journal-title":"J Neurosurg"},{"key":"1978_CR13","first-page":"35","volume":"3","author":"WK Yung","year":"1985","unstructured":"Yung WK, Luna M, Borit A (1985) Vimentin and glial fibrillary acidic protein in human brain tumors. J Neurooncol 3:35\u201338","journal-title":"J Neurooncol"},{"key":"1978_CR14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10517-011-1236-9","volume":"150","author":"NV Lyubimova","year":"2011","unstructured":"Lyubimova NV, Toms MG, Popova EE, Bondarenko YV, Krat VB, Kushlinskii NE (2011) Neurospecific proteins in the serum of patients with brain tumors. Bull Exp Biol Med 150:732\u2013734","journal-title":"Bull Exp Biol Med"},{"key":"1978_CR15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.resuscitation.2014.09.007","volume":"85","author":"IM Larsson","year":"2014","unstructured":"Larsson IM, Wallin E, Kristofferzon ML, Niessner M, Zetterberg H, Rubertsson S (2014) Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. Resuscitation 85:1654\u20131661","journal-title":"Resuscitation"},{"key":"1978_CR16","doi-asserted-by":"crossref","first-page":"e62101","DOI":"10.1371\/journal.pone.0062101","volume":"8","author":"CA Mayer","year":"2013","unstructured":"Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C (2013) Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS One 8:e62101","journal-title":"PLoS One"},{"key":"1978_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1750-3639.1993.tb00752.x","volume":"3","author":"P Kleihues","year":"1993","unstructured":"Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255\u2013268","journal-title":"Brain Pathol"},{"key":"1978_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2990.2010.01100.x","volume":"36","author":"PN Harter","year":"2010","unstructured":"Harter PN, Bunz B, Dietz K, Hoffmann K, Meyermann R, Mittelbronn M (2010) Spatio-temporal deleted in colorectal cancer (DCC) and netrin-1 expression in human foetal brain development. Neuropathol Appl Neurobiol 36:623\u2013635","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1978_CR19","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.7314\/APJCP.2014.15.24.10893","volume":"15","author":"K Wang","year":"2014","unstructured":"Wang K, Wang YY, Ma J, Wang JF, Li SW, Jiang T, Dai JP (2014) Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation. Asian Pac J Cancer Prev 15:10893\u201310898","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"1978_CR20","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1078-0432.CCR-14-2737","volume":"21","author":"M Weller","year":"2015","unstructured":"Weller M, Tabatabai G, Kastner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bahr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Husing J, Reifenberger G, Wick W (2015) MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial. Clin Cancer Res 21(9):2057\u20132064","journal-title":"Clin Cancer Res"},{"key":"1978_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000360582","volume":"92","author":"LM Weise","year":"2014","unstructured":"Weise LM, Harter PN, Eibach S, Braczynski AK, Dunst M, Rieger J, Bahr O, Hattingen E, Steinbach JP, Plate KH, Seifert V, Mittelbronn M (2014) Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsies. Stereotact Funct Neurosurg 92:129\u2013139","journal-title":"Stereotact Funct Neurosurg"},{"key":"1978_CR22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.27.8.1304","volume":"27","author":"RU Kothari","year":"1996","unstructured":"Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304\u20131305","journal-title":"Stroke"},{"key":"1978_CR23","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1089\/neu.2013.3245","volume":"31","author":"L Papa","year":"2014","unstructured":"Papa L, Silvestri S, Brophy GM, Giordano P, Falk JL, Braga CF, Tan CN, Ameli NJ, Demery JA, Dixit NK, Mendes ME, Hayes RL, Wang KK, Robertson CS (2014) GFAP out-performs S100beta in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotrauma 31:1815\u20131822","journal-title":"J Neurotrauma"},{"key":"1978_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2014.12.027","volume":"1600","author":"A Petzold","year":"2015","unstructured":"Petzold A (2015) Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res 1600:17\u201331","journal-title":"Brain Res"},{"key":"1978_CR25","first-page":"40","volume":"71\u201372","author":"NV Lyubimova","year":"2013","unstructured":"Lyubimova NV, Toms MG, Fu RG, Bondarenko YV (2013) Biochemical markers of brain tumours. Klin Lab Diagn 71\u201372:40\u201372","journal-title":"Klin Lab Diagn"},{"key":"1978_CR26","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1038\/sj.onc.1206372","volume":"22","author":"U Wilhelmsson","year":"2003","unstructured":"Wilhelmsson U, Eliasson C, Bjerkvig R, Pekny M (2003) Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression. Oncogene 22:3407\u20133411","journal-title":"Oncogene"},{"key":"1978_CR27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12975-010-0040-6","volume":"1","author":"R Brunkhorst","year":"2010","unstructured":"Brunkhorst R, Pfeilschifter W, Foerch C (2010) Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Transl Stroke Res 1:246\u2013251","journal-title":"Transl Stroke Res"},{"issue":"7","key":"1978_CR28","doi-asserted-by":"crossref","first-page":"dju161","DOI":"10.1093\/jnci\/dju161","volume":"106","author":"F Noreen","year":"2014","unstructured":"Noreen F, Roosli M, Gaj P, Pietrzak J, Weis S, Urfer P, Regula J, Schar P, Truninger K (2014) Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. J Natl Cancer Inst 106(7):dju161","journal-title":"J Natl Cancer Inst"},{"key":"1978_CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-015-1829-7","volume":"124","author":"A Kiviniemi","year":"2015","unstructured":"Kiviniemi A, Gardberg M, Frantzen J, Parkkola R, Vuorinen V, Pesola M, Minn H (2015) Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival. J Neurooncol 124:237\u2013245","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1978-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1978-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:22:56Z","timestamp":1559348576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1978-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1978-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}